Vaxart, Inc. (NASDAQ:VXRT) Q3 2023 Earnings Call Transcript

Page 2 of 2

Brant Biehn : Excellent. Thank you very much. Phil there is another financial question regarding the gate study. So the question to you, Phil is how much revenue is left to be recognized from the gate study and the over what time is that? Phil?

Phil Lee: Sure. Thanks, Brant. So we recognize grant revenue in the period of which the related costs are incurred and services are rendered. So at this point, we really have recognized the vast majority of the current grant from the Bill Melinda Gates Foundation as revenue. I currently expect to recognize the remaining $79,000 in the fourth quarter of 2023.

Brant Biehn : Excellent. Thank you, Phil. Okay, and operator that closes our Q&A.

Operator: Thank you. With that, does that close to this conference? If so, then you may disconnect your lines at this time and have a wonderful day. We thank you for your participation today.

Follow Vaxart Inc. (NASDAQ:VXRT)

Page 2 of 2